Bioventus Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
BVS Nasdaq 3841 https://www.bioventus.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bioventus Inc

Here’s Why Bioventus (BVS) Declined in Q4 - Mar 30th, 2023 8:51 am
Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023 - Mar 29th, 2023 12:55 pm
Are Options Traders Betting on a Big Move in Bioventus (BVS) Stock? - Mar 20th, 2023 2:16 pm
Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023 - Mar 16th, 2023 12:30 pm
Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality – Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition - Feb 28th, 2023 12:30 pm
Bioventus to divest assets ahead of major payments coming due - Jan 27th, 2023 7:49 pm
15 Largest Orthopedic Companies in the World - Jan 14th, 2023 8:14 pm
Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference - Jan 4th, 2023 12:00 pm
2022 Year in Review: Layoffs hit Triangle biotech, pharma companies - Dec 27th, 2022 7:53 pm
Durham's Bioventus slashing headcount to rein in expenses - Dec 9th, 2022 4:58 pm
Why this Durham firm's stock is down more than 70% this month - Nov 29th, 2022 3:34 am
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance - Nov 21st, 2022 10:15 pm
Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022 - Nov 16th, 2022 10:15 pm
Bioventus Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag - Nov 10th, 2022 10:38 am
Why Shares of Bioventus Fell 14% on Wednesday - Nov 9th, 2022 11:18 pm
Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance - Nov 8th, 2022 12:30 pm
Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022 - Oct 31st, 2022 11:00 am
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago - Oct 12th, 2022 12:00 pm
Bioventus to Present at the Morgan Stanley Global Healthcare Conference - Aug 30th, 2022 12:00 pm
Bioventus Inc. (BVS) Q2 2022 Earnings Call Transcript - Aug 12th, 2022 6:32 am